Cargando…
AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2
AICAR (Acadesine) is a pharmacological precursor of purine nucleotide biosynthesis with anti-tumoral properties. Although recognized as an AMP mimetic activator of the protein kinase AMPK, the AICAR monophosphate derivative ZMP was also shown to mediate AMPK-independent effects. In order to unveil t...
Autores principales: | Philippe, Chloé, Pinson, Benoît, Dompierre, Jim, Pantesco, Véronique, Viollet, Benoît, Daignan-Fornier, Bertrand, Moenner, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994775/ https://www.ncbi.nlm.nih.gov/pubmed/29730476 http://dx.doi.org/10.1016/j.neo.2018.03.006 |
Ejemplares similares
-
5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects
por: Daignan-Fornier, Bertrand, et al.
Publicado: (2012) -
On-demand utilization of phosphoribosyl pyrophosphate by downstream anabolic pathways
por: Pinson, Benoît, et al.
Publicado: (2023) -
Yeast to Study Human Purine Metabolism Diseases
por: Daignan-Fornier, Bertrand, et al.
Publicado: (2019) -
A pharmaco-epistasis strategy reveals a new cell size controlling pathway in yeast
por: Moretto, Fabien, et al.
Publicado: (2013) -
Dual control of NAD(+) synthesis by purine metabolites in yeast
por: Pinson, Benoît, et al.
Publicado: (2019)